Brian Adams insider trades: Kymera Therapeutics (KYMR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
62 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | KYMR | ↓ Sell | 6,371 | $116.83 | $744K | Direct | Sep 4, 2026 (0d) |
| Jul 29, 2025 | RLAY | ↓ Sell | 19,913 | $3.68 | $73K | Direct | Jul 30, 2025 (1d) |
| Apr 30, 2025 | RLAY | ↓ Sell | 14,587 | $3.02 | $44K | Direct | Apr 30, 2025 (0d) |
| Mar 27, 2025 | RLAY | ↓ Sell | 298 | $2.84 | $846 | Direct | Mar 31, 2025 (4d) |
| Jan 30, 2025 | RLAY | ↓ Sell | 54,479 | $4.55 | $248K | Direct | Jan 30, 2025 (0d) |
| Dec 27, 2024 | RLAY | ↓ Sell | 299 | $4.38 | $1K | Direct | Dec 31, 2024 (4d) |
| Oct 28, 2024 | RLAY | ↓ Sell | 1,632 | $6.06 | $10K | Direct | Oct 30, 2024 (2d) |
| Sep 27, 2024 | RLAY | ↓ Sell | 295 | $7.51 | $2K | Direct | Oct 1, 2024 (4d) |
| Jul 29, 2024 | RLAY | ↓ Sell | 1,638 | $8.85 | $14K | Direct | Jul 31, 2024 (2d) |
| Jun 27, 2024 | RLAY | ↓ Sell | 295 | $6.26 | $2K | Direct | Jul 1, 2024 (4d) |
| Apr 29, 2024 | RLAY | ↓ Sell | 1,623 | $6.38 | $10K | Direct | Apr 29, 2024 (0d) |
| Mar 27, 2024 | RLAY | ↓ Sell | 348 | $7.70 | $3K | Direct | Mar 29, 2024 (2d) |
| Jan 29, 2024 | RLAY | ↓ Sell | 1,929 | $9.64 | $19K | Direct | Jan 31, 2024 (2d) |
| Dec 27, 2023 | RLAY | ↓ Sell | 294 | $11.51 | $3K | Direct | Dec 29, 2023 (2d) |
| Oct 30, 2023 | RLAY | ↓ Sell | 1,632 | $6.03 | $10K | Direct | Nov 1, 2023 (2d) |
| Sep 27, 2023 | RLAY | ↓ Sell | 294 | $8.38 | $2K | Direct | Sep 29, 2023 (2d) |
| Jul 28, 2023 | RLAY | ↓ Sell | 1,628 | $11.80 | $19K | Direct | Jul 31, 2023 (3d) |
| Jun 27, 2023 | RLAY | ↓ Sell | 294 | $12.12 | $4K | Direct | Jun 28, 2023 (1d) |
| Apr 28, 2023 | RLAY | ↓ Sell | 863 | $11.16 | $10K | Direct | May 1, 2023 (3d) |
| Mar 27, 2023 | RLAY | ↓ Sell | 347 | $15.36 | $5K | Direct | Mar 28, 2023 (1d) |
| Jan 30, 2023 | RLAY | ↓ Sell | 864 | $21.56 | $19K | Direct | Jan 31, 2023 (1d) |
| Jan 12, 2023 | RLAY | ↓ Sell | 9,994 | $20.00 | $200K | Direct | Jan 13, 2023 (1d) |
| Dec 27, 2022 | RLAY | ↓ Sell | 295 | $14.49 | $4K | Direct | Dec 28, 2022 (1d) |
| Oct 28, 2022 | RLAY | ↓ Sell | 728 | $21.54 | $16K | Direct | Nov 1, 2022 (4d) |
| Sep 27, 2022 | RLAY | ↓ Sell | 294 | $22.73 | $7K | Direct | Sep 29, 2022 (2d) |
| Jul 28, 2022 | RLAY | ↓ Sell | 734 | $21.27 | $16K | Direct | Jul 29, 2022 (1d) |
| Jun 27, 2022 | RLAY | ↓ Sell | 300 | $20.31 | $6K | Direct | Jun 28, 2022 (1d) |
| Apr 28, 2022 | RLAY | ↓ Sell | 708 | $25.57 | $18K | Direct | May 2, 2022 (4d) |
| Mar 29, 2022 | RLAY | ↓ Sell | 333 | $29.87 | $10K | Direct | Mar 31, 2022 (2d) |
| Dec 27, 2021 | RLAY | ↓ Sell | 295 | $33.10 | $10K | Direct | Dec 27, 2021 (0d) |
| Nov 15, 2021 | RLAY | ↓ Sell | 6,500 | $35.42 | $230K | Direct | Nov 16, 2021 (1d) |
| Sep 27, 2021 | RLAY | ↓ Sell | 293 | $36.87 | $11K | Direct | Sep 27, 2021 (0d) |
| Sep 13, 2021 | RLAY | ↓ Sell | 6,500 | $35.02 | $228K | Direct | Sep 13, 2021 (0d) |
| Jun 28, 2021 | RLAY | ↓ Sell | 293 | $35.81 | $10K | Direct | Jun 30, 2021 (2d) |
| Jun 7, 2021 | RLAY | ↓ Sell | 6,500 | $35.00 | $228K | Direct | Jun 9, 2021 (2d) |
| Apr 26, 2021 | RLAY | ↓ Sell | 6,500 | $35.00 | $228K | Direct | Apr 28, 2021 (2d) |
| Jan 28, 2021 | RLAY | ↓ Sell | 5,000 | $55.05 | $275K | Direct | Jan 29, 2021 (1d) |
| Jul 20, 2020 | RLAY | ↑ Buy | 10,000 | $20.00 | $200K | Direct | Jul 21, 2020 (1d) |
| Feb 15, 2018 | KERX | ↓ Sell | 5,652 | $4.81 | $27K | Direct | Feb 16, 2018 (1d) |
| Jan 29, 2018 | KERX | ↓ Sell | 1,541 | $4.81 | $7K | Direct | Jan 31, 2018 (2d) |
| Jan 5, 2018 | KERX | ↓ Sell | 753 | $4.69 | $4K | Direct | Jan 8, 2018 (3d) |
| Oct 30, 2017 | KERX | ↓ Sell | 1,405 | $6.03 | $8K | Direct | Oct 31, 2017 (1d) |
| Oct 5, 2017 | KERX | ↓ Sell | 630 | $7.19 | $5K | Direct | Oct 6, 2017 (1d) |
| Jul 31, 2017 | KERX | ↓ Sell | 1,445 | $7.14 | $10K | Direct | Aug 1, 2017 (1d) |
| Jul 5, 2017 | KERX | ↓ Sell | 641 | $7.67 | $5K | Direct | Jul 6, 2017 (1d) |
| May 1, 2017 | KERX | ↓ Sell | 1,441 | $5.97 | $9K | Direct | May 3, 2017 (2d) |
| Apr 17, 2017 | KERX | ↓ Sell | 1,090 | $5.75 | $6K | Direct | Apr 18, 2017 (1d) |
| Apr 5, 2017 | KERX | ↓ Sell | 642 | $5.80 | $4K | Direct | Apr 6, 2017 (1d) |
| Jan 30, 2017 | KERX | ↓ Sell | 6,984 | $4.65 | $32K | Direct | Jan 31, 2017 (1d) |
| Jan 17, 2017 | KERX | ↓ Sell | 1,265 | $6.24 | $8K | Direct | Jan 18, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KYMR insiders
Open-market trades in the last 12 months
About Brian Adams's insider trades
Brian Adams is Chief Legal Officer at Kymera Therapeutics (KYMR). Since Apr 15, 2015, Brian has reported 1 open-market purchase worth $200K and 61 sales worth $3.0M on SEC Form 4. In the last 12 months: 1 sale ($744K).
Their filings also include grants and awards (12 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.